Acefylline

DB13573

small molecule experimental

Deskripsi

Struktur Molekul 2D

Berat 238.203
Wujud -

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

605 Data
Deferasirox The serum concentration of Acefylline can be increased when it is combined with Deferasirox.
Peginterferon alfa-2b The serum concentration of Acefylline can be increased when it is combined with Peginterferon alfa-2b.
Leflunomide The serum concentration of Acefylline can be decreased when it is combined with Leflunomide.
Teriflunomide The serum concentration of Acefylline can be decreased when it is combined with Teriflunomide.
Regadenoson Acefylline may decrease effectiveness of Regadenoson as a diagnostic agent.
Adalimumab The serum concentration of Acefylline can be decreased when it is combined with Adalimumab.
Adenosine The therapeutic efficacy of Adenosine can be decreased when used in combination with Acefylline.
Allopurinol The serum concentration of Acefylline can be increased when it is combined with Allopurinol.
Carbamazepine The serum concentration of Acefylline can be decreased when it is combined with Carbamazepine.
Cimetidine The metabolism of Acefylline can be decreased when combined with Cimetidine.
Disulfiram The serum concentration of Acefylline can be increased when it is combined with Disulfiram.
Febuxostat The serum concentration of the active metabolites of Acefylline can be increased when Acefylline is used in combination with Febuxostat.
Fluvoxamine The metabolism of Acefylline can be decreased when combined with Fluvoxamine.
Formoterol The risk or severity of hypokalemia can be increased when Acefylline is combined with Formoterol.
Indacaterol The risk or severity of adverse effects can be increased when Acefylline is combined with Indacaterol.
Isoniazid The serum concentration of Acefylline can be increased when it is combined with Isoniazid.
Lithium citrate The serum concentration of Lithium citrate can be decreased when it is combined with Acefylline.
Lithium carbonate The serum concentration of Lithium carbonate can be decreased when it is combined with Acefylline.
Lithium hydroxide The serum concentration of Lithium hydroxide can be decreased when it is combined with Acefylline.
Mexiletine The metabolism of Acefylline can be decreased when combined with Mexiletine.
Olodaterol Acefylline may increase the hyperkalemic activities of Olodaterol.
Pancuronium The therapeutic efficacy of Pancuronium can be decreased when used in combination with Acefylline.
Pentoxifylline The serum concentration of Acefylline can be increased when it is combined with Pentoxifylline.
Phenytoin The serum concentration of Acefylline can be decreased when it is combined with Phenytoin.
Fosphenytoin The serum concentration of Acefylline can be decreased when it is combined with Fosphenytoin.
Propafenone The serum concentration of Acefylline can be increased when it is combined with Propafenone.
Quinine The serum concentration of Acefylline can be increased when it is combined with Quinine.
Quinidine The serum concentration of Acefylline can be increased when it is combined with Quinidine.
Riociguat Acefylline may increase the hypotensive activities of Riociguat.
Thiabendazole The metabolism of Acefylline can be decreased when combined with Thiabendazole.
Ticlopidine The metabolism of Acefylline can be decreased when combined with Ticlopidine.
Zafirlukast The serum concentration of Zafirlukast can be decreased when it is combined with Acefylline.
Probenecid The serum concentration of Acefylline can be increased when it is combined with Probenecid.
Abiraterone The serum concentration of Acefylline can be increased when it is combined with Abiraterone.
Isoprenaline The serum concentration of Acefylline can be decreased when it is combined with Isoprenaline.
Cyproterone acetate The metabolism of Acefylline can be increased when combined with Cyproterone acetate.
Amphetamine The risk or severity of adverse effects can be increased when Amphetamine is combined with Acefylline.
Phentermine The risk or severity of adverse effects can be increased when Phentermine is combined with Acefylline.
Midodrine The risk or severity of adverse effects can be increased when Midodrine is combined with Acefylline.
Norepinephrine The risk or severity of adverse effects can be increased when Norepinephrine is combined with Acefylline.
Phenylephrine The risk or severity of adverse effects can be increased when Phenylephrine is combined with Acefylline.
Phenylpropanolamine The risk or severity of adverse effects can be increased when Phenylpropanolamine is combined with Acefylline.
Labetalol The risk or severity of adverse effects can be increased when Labetalol is combined with Acefylline.
Metaraminol The risk or severity of adverse effects can be increased when Metaraminol is combined with Acefylline.
Epinephrine The risk or severity of adverse effects can be increased when Epinephrine is combined with Acefylline.
Methoxamine The risk or severity of adverse effects can be increased when Methoxamine is combined with Acefylline.
Orciprenaline The risk or severity of adverse effects can be increased when Orciprenaline is combined with Acefylline.
Phenmetrazine The risk or severity of adverse effects can be increased when Phenmetrazine is combined with Acefylline.
Dobutamine The risk or severity of adverse effects can be increased when Dobutamine is combined with Acefylline.
Pseudoephedrine The risk or severity of adverse effects can be increased when Pseudoephedrine is combined with Acefylline.
Benzphetamine The risk or severity of adverse effects can be increased when Benzphetamine is combined with Acefylline.
Ritodrine The risk or severity of adverse effects can be increased when Ritodrine is combined with Acefylline.
Terbutaline The risk or severity of adverse effects can be increased when Terbutaline is combined with Acefylline.
Oxymetazoline The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Acefylline.
Diethylpropion The risk or severity of adverse effects can be increased when Diethylpropion is combined with Acefylline.
Dopamine The risk or severity of adverse effects can be increased when Dopamine is combined with Acefylline.
Acebutolol The risk or severity of adverse effects can be increased when Acebutolol is combined with Acefylline.
Lisdexamfetamine The risk or severity of adverse effects can be increased when Lisdexamfetamine is combined with Acefylline.
Fenoterol The risk or severity of adverse effects can be increased when Fenoterol is combined with Acefylline.
Ephedrine The risk or severity of adverse effects can be increased when Ephedrine is combined with Acefylline.
Mephentermine The risk or severity of adverse effects can be increased when Mephentermine is combined with Acefylline.
Procaterol The risk or severity of adverse effects can be increased when Procaterol is combined with Acefylline.
Clenbuterol The risk or severity of adverse effects can be increased when Clenbuterol is combined with Acefylline.
MMDA The risk or severity of adverse effects can be increased when MMDA is combined with Acefylline.
Midomafetamine The risk or severity of adverse effects can be increased when Midomafetamine is combined with Acefylline.
2,5-Dimethoxy-4-ethylamphetamine The risk or severity of adverse effects can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Acefylline.
4-Bromo-2,5-dimethoxyamphetamine The risk or severity of adverse effects can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Acefylline.
Tenamfetamine The risk or severity of adverse effects can be increased when Tenamfetamine is combined with Acefylline.
Chlorphentermine The risk or severity of adverse effects can be increased when Chlorphentermine is combined with Acefylline.
Methylenedioxyethamphetamine The risk or severity of adverse effects can be increased when Methylenedioxyethamphetamine is combined with Acefylline.
Dextroamphetamine The risk or severity of adverse effects can be increased when Dextroamphetamine is combined with Acefylline.
Metamfetamine The risk or severity of adverse effects can be increased when Metamfetamine is combined with Acefylline.
Celiprolol The risk or severity of adverse effects can be increased when Celiprolol is combined with Acefylline.
Nylidrin The risk or severity of adverse effects can be increased when Nylidrin is combined with Acefylline.
Tetryzoline The risk or severity of adverse effects can be increased when Tetryzoline is combined with Acefylline.
Tyramine The risk or severity of adverse effects can be increased when Tyramine is combined with Acefylline.
Isoxsuprine The risk or severity of adverse effects can be increased when Isoxsuprine is combined with Acefylline.
Etilefrine The risk or severity of adverse effects can be increased when Etilefrine is combined with Acefylline.
Synephrine The risk or severity of adverse effects can be increased when Synephrine is combined with Acefylline.
Hydroxyamphetamine The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Acefylline.
Iofetamine I-123 The risk or severity of adverse effects can be increased when Iofetamine I-123 is combined with Acefylline.
Racepinephrine The risk or severity of adverse effects can be increased when Racepinephrine is combined with Acefylline.
Ritobegron The risk or severity of adverse effects can be increased when Ritobegron is combined with Acefylline.
Bucindolol The risk or severity of adverse effects can be increased when Bucindolol is combined with Acefylline.
Tramazoline The risk or severity of adverse effects can be increased when Tramazoline is combined with Acefylline.
Mephedrone The risk or severity of adverse effects can be increased when Mephedrone is combined with Acefylline.
Fenozolone The risk or severity of adverse effects can be increased when Fenozolone is combined with Acefylline.
Methoxyphenamine The risk or severity of adverse effects can be increased when Methoxyphenamine is combined with Acefylline.
Tretoquinol The risk or severity of adverse effects can be increased when Tretoquinol is combined with Acefylline.
Gepefrine The risk or severity of adverse effects can be increased when Gepefrine is combined with Acefylline.
Epanolol The risk or severity of adverse effects can be increased when Epanolol is combined with Acefylline.
Prenalterol The risk or severity of adverse effects can be increased when Prenalterol is combined with Acefylline.
Mefenorex The risk or severity of adverse effects can be increased when Mefenorex is combined with Acefylline.
2,5-Dimethoxy-4-ethylthioamphetamine The risk or severity of adverse effects can be increased when 2,5-Dimethoxy-4-ethylthioamphetamine is combined with Acefylline.
Esmolol The risk or severity of adverse effects can be increased when Esmolol is combined with Acefylline.
Betaxolol The risk or severity of adverse effects can be increased when Betaxolol is combined with Acefylline.
Metoprolol The risk or severity of adverse effects can be increased when Metoprolol is combined with Acefylline.
Atenolol The risk or severity of adverse effects can be increased when Atenolol is combined with Acefylline.
Timolol The risk or severity of adverse effects can be increased when Timolol is combined with Acefylline.
Sotalol The risk or severity of adverse effects can be increased when Sotalol is combined with Acefylline.

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul